Stocks Health care MTNB
NYSE · Health careMatinas BioPharma Holdings, Inc. (MTNB)
It posted a net loss of $6.7M. At June 30, 2026 it held $761K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Matinas BioPharma Holdings, Inc. does
Matinas BioPharma Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker MTNB.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$10.3M | -$2.00 | n/a |
| 2024 | n/a | -$24.3M | -$4.98 | n/a |
| 2023 | $1.1M | -$22.9M | -$5.28 | -$15.5M |
| 2022 | $3.2M | -$21M | -$4.80 | -$20M |
| 2021 | $33K | -$23.3M | -$5.28 | -$15.5M |
| 2020 | $158.3K | -$22.4M | -$5.76 | -$17.4M |
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Matinas BioPharma Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 16, 2026Other event 8-K
- September 4, 2026
- August 25, 2026Form 425 filing 425
- August 13, 2026
- August 13, 2026Activist stake changed SCHEDULE 13D/A
- August 4, 2026Form 425 filing 425
- July 30, 2026Form 425 filing 425
- July 29, 2026Form 425 filing 425
- July 24, 2026
- July 21, 2026Form 425 filing 425
Insider trades
What the people running Matinas BioPharma Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 2 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 10, 2026 | Stern Adam K10% owner | Exercised optionsindirect | 344,710 | $120.6K |
| July 10, 2026 | Stern Adam K10% owner | Exercised optionsindirect | 630,335 | $220.6K |
| October 31, 2025 | Stern Adam K10% owner | Exercised optionsindirect | 92,100 | $59.4K |
Who owns MTNB
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Stern Adam K13D, may seek influence with 1 related filers | 9.99% | August 13, 2026 |
| Hezbay Holdings LLC13G, passive | 9.54% | July 14, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 743,785 shares in total, about $119K at the last price.
| Holder | Shares |
|---|---|
| Stern Adam K10% owner | 743,785743,785 held indirectly |
Questions about MTNB
What does Matinas BioPharma Holdings, Inc. do?
Matinas BioPharma Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker MTNB.
Is Matinas BioPharma Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $6.7M.
When did Matinas BioPharma Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 16, 2026.
Similar companies
Compare MTNB with
Follow MTNB
Get an email when Matinas BioPharma Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow MTNB: get an email when it filesWhere the numbers come from
Financial figures are the values Matinas BioPharma Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.